These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22476470)

  • 21. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
    Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance.
    De Raeve HR; Vermeulen PB; Vanderkerken K; Harris AL; Van Marck E
    Virchows Arch; 2004 Jul; 445(1):27-35. PubMed ID: 15168117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
    Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
    Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
    Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
    Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
    World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil.
    van der Wal GE; Gouw AS; Kamps JA; Moorlag HE; Bulthuis ML; Molema G; de Jong KP
    Ann Surg; 2012 Jan; 255(1):86-94. PubMed ID: 22156924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition.
    Colpaert CG; Vermeulen PB; Van Beest P; Soubry A; Goovaerts G; Dirix LY; Harris AL; Van Marck EA
    Histopathology; 2003 Jun; 42(6):530-40. PubMed ID: 12786888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases.
    Khellaf L; Quénet F; Jarlier M; Gil H; Pissas MH; Carrère S; Samalin E; Mazard T; Ychou M; Sgarbura O; Bibeau F
    Surgery; 2022 Nov; 172(5):1434-1441. PubMed ID: 36089423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
    Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
    Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration.
    Abe H; Yasunaga Y; Yamazawa S; Nakai Y; Gonoi W; Nishioka Y; Murono K; Sasaki K; Arita J; Kawai K; Nozawa H; Hasegawa K; Ishihara S; Ushiku T
    Hum Pathol; 2022 May; 123():74-83. PubMed ID: 35247436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
    Heijmen L; de Geus-Oei LF; de Wilt JH; Visvikis D; Hatt M; Visser EP; Bussink J; Punt CJ; Oyen WJ; van Laarhoven HW
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1858-67. PubMed ID: 22945372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7.
    Huber AR; Tan D; Sun J; Dean D; Wu T; Zhou Z
    BMC Gastroenterol; 2015 Jul; 15():80. PubMed ID: 26156831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.